Search Results - "La Rosée, L"

Social feedback processing in borderline personality disorder by Korn, C W, La Rosée, L, Heekeren, H R, Roepke, S

“…Patients with borderline personality disorder (BPD) show negative and unstable self- and other-evaluations compared to healthy individuals. It is unclear,…”
Get more information

Submental intubation for cancrum oris: a case report by EIPE, NAVEEN, NEUHOEFER, EVA‐SABINE, ROSEE, GABRIELE LA, CHOUDHRIE, RAJIV, SAMMAN, NABIL, KREUSCH, THOMAS

“…Summary Cancrum oris (Noma) is a devastating gangrenous disease that leads to severe tissue destruction in the face. We describe the anesthetic management of a…”
Get full text

Several Bcr-Abl kinase domain mutants associated with imatinib mesylate resistance remain sensitive to imatinib by Corbin, Amie S., Rosée, Paul La, Stoffregen, Eric P., Druker, Brian J., Deininger, Michael W.

“…Imatinib mesylate is a selective Bcr-Abl kinase inhibitor, effective in the treatment of chronic myelogenous leukemia. Most patients in chronic phase maintain…”
Get full text

Choosing the best treatment strategy for chronic myeloid leukemia patients resistant to imatinib: weighing the efficacy and safety of individual drugs with BCR-ABL mutations and patient history by Jabbour, E, Hochhaus, A, Cortes, J, La Rosée, P, Kantarjian, H M

“…For patients with chronic myeloid leukemia who become or are inherently resistant to imatinib therapy, including dose escalation, several important factors…”
Get full text

Resistance to Imatinib: Mutations and Beyond: Chronic Myeloid Leukemia in the Imatinib Era by LA ROSEE, Paul, DEININGER, Michael W

Get full text

Omacetaxine mepesuccinate prevents cytokine-dependent resistance to nilotinib in vitro: potential role of the common β-subunit c of cytokine receptors by Klag, T, Härtel, N, Erben, P, Schwaab, J, Schnetzke, U, Schenk, T, Hochhaus, A, La Rosée, P

“…Overcoming resistance against BCR-ABL-inhibitors in chronic myeloid leukemia (CML) is central to prevent progression to advanced phase disease. Kinase…”
Get full text

BCR-ABL Mutations in Chronic Myeloid Leukemia: Chronic Myelogenous Leukemia by ERNST, Thomas, LA ROSEE, Paul, MÜLLER, Martin C, HOCHHAUS, Andreas

Get full text

In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia by La Rosée, Paul, Johnson, Kara, O'Dwyer, Michael E, Druker, Brian J

“…The aim of this study was the preclinical evaluation of imatinib mesylate (Gleevec, formerly STI571) in conjunction with arsenic trioxide (As 2O 3, Trisenox)…”
Get full text

Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970 by Corbin, Amie S., Griswold, Ian J., La Rosée, Paul, Yee, Kevin W.H., Heinrich, Michael C., Reimer, Corinne L., Druker, Brian J., Deininger, Michael W.N.

“…Oncogenic mutations of the receptor tyrosine kinase KIT occur in gastrointestinal stromal tumors (GISTs), some cases of acute myelogenous leukemia (AML), and…”
Get full text

In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl–positive cell lines by La Rosée, Paul, Johnson, Kara, Corbin, Amie S., Stoffregen, Eric P., Moseson, Erika M., Willis, Stephanie, Mauro, Michael M., Melo, Junia V., Deininger, Michael W., Druker, Brian J.

“…Imatinib mesylate (Gleevec, formerly STI571) is an effective therapy for all stages of chronic myelogenous leukemia (CML). While responses in chronic-phase CML…”
Get full text

Systemic mastocytosis simulating osseous metastatic disease by Metzgeroth, Georgia, Dinter, Dietmar, Erben, Philipp, Rosée, Paul La, Hehlmann, Rüdiger, Hastka, Jan

Get full text

Effects of MLN518, a dual FLT3 and KIT inhibitor, on normal and malignant hematopoiesis by Griswold, Ian J., Shen, Lei J., La Rosée, Paul, Demehri, Shadmehr, Heinrich, Michael C., Braziel, Rita M., McGreevey, Laura, Haley, Andrea D., Giese, Neill, Druker, Brian J., Deininger, Michael W.N.

“…Internal tandem duplications (ITDs) of the FMS-like tyrosine kinase 3 (FLT3) receptor tyrosine kinase are found in approximately 30% of patients with acute…”
Get full text

Insights from pre-clinical studies for new combination treatment regimens with the Bcr-Abl kinase inhibitor imatinib mesylate (Gleevec/Glivec) in chronic myelogenous leukemia: a translational perspective : Spotlight on signal transduction inhibitors: Basic aspects and therapeutics implications by LA ROSEE, P, O'DWYER, M. E, DRUKER, B. I

Get full text

Recent advances in Philadelphia chromosome-positive malignancies: The potential role of arsenic trioxide: Arsenic trioxide as a selective anticancer agent: rationale and clinical utility by O'DWYER, Michael E, LA ROSEE, Paul, NIMMANAPALLI, Ramedivi, BHALLA, Kapil N, DRUKER, Brian J

Get full text

Studies on normal hearing capacity in different ages with special reference to audiometric tests by DE LA ROSEE, B

Get more information

Therapy of hypertension with hydrazinophthalazines by KUMMER, P, LA ROSEE, R

Get more information

The Arg389Gly β1-adrenoceptor gene polymorphism determines contractile response to catecholamines by LA ROSEE, Karl, HUNTGEBURTH, Michael, ROSENKRANZ, Stephan, BÖHM, Michael, SCHNABEL, Petra

Get full text

Effects of angiotensin II and angiotensin-converting enzyme inhibitors on human myocardium by Lenz, Olaf, Schmid, Bernhard, Kilter, Heiko, La Rosé, Karl, Flesch, Markus, Kuhn-Regnier, Ferdinand, Südkamp, Michael, Böhm, Michael

“…Human myocardial angiotensin II receptors and the angiotensin AT 1 and AT 2 receptor subtypes were characterised using the partial angiotensin II receptor…”
Get full text

Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium by Schwinger, R H, Böhm, M, Mittmann, C, La Rosée, K, Erdmann, E

“…Elevation of cytosolic sodium is thought to be correlated with an increase in force of contraction due to an activation of sodium-calcium exchange. We…”
Get more information

Existence of PAF receptors in human platelets and human lung tissue but not in the human myocardium by Schwinger, R H, Böhm, M, La Rosée, K, Erdmann, E

“…The aim of this study was to investigate whether platelet-activating factor (PAF), PAF receptors, and PAF receptor-mediated effects in the human myocardium…”
Get more information